Cargando…

HCV poly U/UC sequence–induced inflammation leads to metabolic disorders in vulvar lichen sclerosis

Vulvar lichen sclerosis (VLS) is a dermatologic disorder that affects women worldwide. Women with VLS have white, atrophic papules on the vulva. They suffer from life-long intense pruritus. Corticosteroids are the first-line of treatments and the most effective medicines for VLS. Although VLS has be...

Descripción completa

Detalles Bibliográficos
Autores principales: Cong, Qing, Guo, Xiao, Zhang, Shengwei, Wang, Jinhui, Zhu, Yi, Wang, Lili, Lu, Guangxing, Zhang, Yufeng, Fu, Wei, Zhou, Liying, Wang, Shuaikang, Liu, Cenxi, Song, Jia, Yang, Chaoyong, Luo, Chi, Ni, Ting, Sui, Long, Huang, He, Li, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Life Science Alliance LLC 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321666/
https://www.ncbi.nlm.nih.gov/pubmed/34145025
http://dx.doi.org/10.26508/lsa.202000906
_version_ 1783730899481788416
author Cong, Qing
Guo, Xiao
Zhang, Shengwei
Wang, Jinhui
Zhu, Yi
Wang, Lili
Lu, Guangxing
Zhang, Yufeng
Fu, Wei
Zhou, Liying
Wang, Shuaikang
Liu, Cenxi
Song, Jia
Yang, Chaoyong
Luo, Chi
Ni, Ting
Sui, Long
Huang, He
Li, Jin
author_facet Cong, Qing
Guo, Xiao
Zhang, Shengwei
Wang, Jinhui
Zhu, Yi
Wang, Lili
Lu, Guangxing
Zhang, Yufeng
Fu, Wei
Zhou, Liying
Wang, Shuaikang
Liu, Cenxi
Song, Jia
Yang, Chaoyong
Luo, Chi
Ni, Ting
Sui, Long
Huang, He
Li, Jin
author_sort Cong, Qing
collection PubMed
description Vulvar lichen sclerosis (VLS) is a dermatologic disorder that affects women worldwide. Women with VLS have white, atrophic papules on the vulva. They suffer from life-long intense pruritus. Corticosteroids are the first-line of treatments and the most effective medicines for VLS. Although VLS has been speculated as an autoimmune disease for a long time, its pathogenesis and the molecular mechanism is largely unknown. We performed a comprehensive multi-omics analysis of paired samples from VLS patients as well as healthy donors. From the RNA-seq analysis, we found that VLS is correlated to abnormal antivirus response because of the presence of Hepatitis C Virus poly U/UC sequences. Lipidomic and metabolomic analysis revealed that inflammation-induced metabolic disorders of fatty acids and glutathione were likely the reasons for pruritus, atrophy, and pigment loss in the vulva. Thus, the present study provides an initial interpretation of the pathogenesis and molecular mechanism of VLS and suggests that metabolic disorders that affect the vulva may serve as therapeutic targets for VLS.
format Online
Article
Text
id pubmed-8321666
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Life Science Alliance LLC
record_format MEDLINE/PubMed
spelling pubmed-83216662021-08-04 HCV poly U/UC sequence–induced inflammation leads to metabolic disorders in vulvar lichen sclerosis Cong, Qing Guo, Xiao Zhang, Shengwei Wang, Jinhui Zhu, Yi Wang, Lili Lu, Guangxing Zhang, Yufeng Fu, Wei Zhou, Liying Wang, Shuaikang Liu, Cenxi Song, Jia Yang, Chaoyong Luo, Chi Ni, Ting Sui, Long Huang, He Li, Jin Life Sci Alliance Research Articles Vulvar lichen sclerosis (VLS) is a dermatologic disorder that affects women worldwide. Women with VLS have white, atrophic papules on the vulva. They suffer from life-long intense pruritus. Corticosteroids are the first-line of treatments and the most effective medicines for VLS. Although VLS has been speculated as an autoimmune disease for a long time, its pathogenesis and the molecular mechanism is largely unknown. We performed a comprehensive multi-omics analysis of paired samples from VLS patients as well as healthy donors. From the RNA-seq analysis, we found that VLS is correlated to abnormal antivirus response because of the presence of Hepatitis C Virus poly U/UC sequences. Lipidomic and metabolomic analysis revealed that inflammation-induced metabolic disorders of fatty acids and glutathione were likely the reasons for pruritus, atrophy, and pigment loss in the vulva. Thus, the present study provides an initial interpretation of the pathogenesis and molecular mechanism of VLS and suggests that metabolic disorders that affect the vulva may serve as therapeutic targets for VLS. Life Science Alliance LLC 2021-06-18 /pmc/articles/PMC8321666/ /pubmed/34145025 http://dx.doi.org/10.26508/lsa.202000906 Text en © 2021 Cong et al. https://creativecommons.org/licenses/by/4.0/This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Articles
Cong, Qing
Guo, Xiao
Zhang, Shengwei
Wang, Jinhui
Zhu, Yi
Wang, Lili
Lu, Guangxing
Zhang, Yufeng
Fu, Wei
Zhou, Liying
Wang, Shuaikang
Liu, Cenxi
Song, Jia
Yang, Chaoyong
Luo, Chi
Ni, Ting
Sui, Long
Huang, He
Li, Jin
HCV poly U/UC sequence–induced inflammation leads to metabolic disorders in vulvar lichen sclerosis
title HCV poly U/UC sequence–induced inflammation leads to metabolic disorders in vulvar lichen sclerosis
title_full HCV poly U/UC sequence–induced inflammation leads to metabolic disorders in vulvar lichen sclerosis
title_fullStr HCV poly U/UC sequence–induced inflammation leads to metabolic disorders in vulvar lichen sclerosis
title_full_unstemmed HCV poly U/UC sequence–induced inflammation leads to metabolic disorders in vulvar lichen sclerosis
title_short HCV poly U/UC sequence–induced inflammation leads to metabolic disorders in vulvar lichen sclerosis
title_sort hcv poly u/uc sequence–induced inflammation leads to metabolic disorders in vulvar lichen sclerosis
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321666/
https://www.ncbi.nlm.nih.gov/pubmed/34145025
http://dx.doi.org/10.26508/lsa.202000906
work_keys_str_mv AT congqing hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis
AT guoxiao hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis
AT zhangshengwei hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis
AT wangjinhui hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis
AT zhuyi hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis
AT wanglili hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis
AT luguangxing hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis
AT zhangyufeng hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis
AT fuwei hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis
AT zhouliying hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis
AT wangshuaikang hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis
AT liucenxi hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis
AT songjia hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis
AT yangchaoyong hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis
AT luochi hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis
AT niting hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis
AT suilong hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis
AT huanghe hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis
AT lijin hcvpolyuucsequenceinducedinflammationleadstometabolicdisordersinvulvarlichensclerosis